Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-04-13

Clinical Trial Update: Transthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer [NA]

View source ↗

Summary

A clinical trial is evaluating transthoracic versus transbronchial radiofrequency ablation for lung cancer (Stage IA) and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Lung Cancer Stage IA | NA | Status: RECRUITING